retatrutide approval 2025 Promises Big Weight Loss, but Safety Remains a Question Is Retatrutide FDA Approved? Current

GIPR augments insulin response and modulates adipose tissue

Research shows that 81% of employers acknowledge the interest of employees in GLP-1 coverage, but only 25% actually offer it, leading to a significant disparity between employee demand and employer offerings

The mobile app ties everything together, allowing patients to message their provider, manage prescriptions, and track weight progress in one place, and the full onboarding process can be started in minutes through the Measured Health official site

Provider review: A licensed clinician determines if GLP-1 medication is appropriate, usually within 24-48 hours

Brand-name Wegovy and Zepbound are sometimes covered for patients with documented obesity (BMI 30+) or BMI 27+ with a comorbid condition